Labeling and Induced Infringement in Pharma Patent Litigation and Protecting IP Rights
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent counsel on the implications of recent litigation strategies and discuss strategic considerations of label language.
- Implications of recent decisions for induced infringement
- Other Federal Circuit induced infringement decisions
- Strategic considerations of label language for induced infringement, including applying the teachings of Sanofi and Vanda
The panel will review these and other noteworthy issues:
- What impact will recent decisions have on proving induced infringement?
- What impact will recent decisions have on claim drafting?
- What strategic considerations should patent owners keep in mind when labeling drugs?
Director, Intellectual Property Litigation
Merck Sharp & Dohme
Mr. Clay is a Director of Global Litigation & Patents at Merck Sharp & Dohme Corp. Prior to Merck, he was Of... | Read More
Mr. Clay is a Director of Global Litigation & Patents at Merck Sharp & Dohme Corp. Prior to Merck, he was Of Counsel at Finnegan, Henderson, Farabow, Garrett & Dunner LLP in Washington, D.C. where he specialized in patent litigation, post-grant proceedings, and appeals related to pharmaceuticals and biologics. Mr. Clay also clerked for the Honorable Kara F. Stoll at the U.S. Court of Appeals for the Federal Circuit and the Honorable Gerald Bruce Lee at the U.S. District Court for the Eastern District of Virginia.Close
Shana K. Cyr, Ph.D., Esq.
Senior Corporate Counsel – IP
Bristol Myers Squibb
Dr. Cyr is Senior Corporate Counsel in the BD and Commercial IP Group of the Innovation Law Department at Bristol Myers... | Read More
Dr. Cyr is Senior Corporate Counsel in the BD and Commercial IP Group of the Innovation Law Department at Bristol Myers Squibb in Princeton, New Jersey. Before joining BMS, she was a partner at one of the world’s largest intellectual property law firms, focusing on complex patent litigations and contentious patent office proceedings relating to pharmaceutical products. Dr. Cyr served as judicial law clerk to the Honorable Kimberly A. Moore at the U.S. Court of Appeals for the Federal Circuit and as judicial intern to the Honorable Noel Hillman at the U.S. District Court for the District of New Jersey. Dr. Cyr holds a J.D. with High Honors from Rutgers University School of Law – Camden, a Ph.D. in chemistry from the University of Virginia, and a B.S. in chemistry with biology and mathematics minors from the University of Richmond.Close
Sterne, Kessler, Goldstein & Fox
Ms. Vira is a director in the firm's Trial & Appellate and Biotechnology & Chemical Practice Groups. She... | Read More
Ms. Vira is a director in the firm's Trial & Appellate and Biotechnology & Chemical Practice Groups. She represents clients in complex patent litigations in federal district courts, in contested proceedings before the Patent Trial and Appeal Board, and before the Federal Circuit on appeal. She litigates cases involving a broad range of technologies in the pharmaceutical, biotechnological, and electrical arts. She focuses her practice on litigating cases involving small-molecule pharmaceuticals under the Hatch-Waxman Act and biologics and biosimilars under the Biologics Price Competition and Innovation Act (BPCIA).Close